ArticlePloS one2021

Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice.

Sushmita Rath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.